Medicare Enrolled
Dr. Ayesha Siddiqui, MD
Family Medicine · New York, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Siddiqui from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Siddiqui?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Siddiqui
Dr. Ayesha Siddiqui is a family medicine specialist in New York, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Siddiqui performed 184,541 Medicare services across 4,027 unique beneficiaries.
Between the years covered by Open Payments, Dr. Siddiqui received a total of $2,570 from 42 pharmaceutical and/or device companies across 124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Siddiqui is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 0% volume in NY
$2,570 industry payments
Medicare Practice Summary
Medicare Utilization ↗184,541
Medicare services
Top 0% in NY for family medicine
4,027
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~10,252 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 94,920 | $8 | $24 |
| Denosumab injection (Prolia/Xgeva) | 38,220 | $18 | $112 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
13,770 | $0 | $7 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
12,100 | $0 | $2 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 11,970 | $38 | $160 |
| Injection, eptinezumab-jjmr, 1 mg | 3,600 | $14 | $30 |
| Injection, benralizumab, 1 mg | 1,680 | $132 | $320 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,171 | $12 | $78 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,050 | $26 | $360 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
940 | $0 | $20 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
812 | $50 | $197 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
789 | $7 | $450 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
502 | $68 | $381 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
490 | $0 | $6 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
401 | $8 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
379 | $58 | $343 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
309 | $11 | $64 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
290 | $8 | $87 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
261 | $96 | $377 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
237 | $19 | $102 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
161 | $26 | $148 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
112 | $116 | $676 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
101 | $1 | $4 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
100 | $14 | $79 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
67 | $25 | $145 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
46 | $1 | $18 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
36 | $1 | $20 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
27 | $2 | $38 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.0% high complexity
89.8% medium
1.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,570
Total received (2018-2024)
Avg $428/year across 6 years
Top 20% in NY for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
124
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,535 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$35 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$140
2023
$488
2022
$860
2021
$631
2020
$417
2018
$35
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$47
GENZYME CORPORATION
$32
Lundbeck LLC
$23
Amgen Inc.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$18
Top 3 companies account for 72.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$441
Lundbeck LLC
$281
Daiichi Sankyo Inc.
$226
Janssen Biotech, Inc.
$185
GlaxoSmithKline, LLC.
$106
Novartis Pharmaceuticals Corporation
$78
Lilly USA, LLC
$70
AMAG Pharmaceuticals, Inc.
$70
Seagen Inc.
$68
Regeneron Healthcare Solutions, Inc.
$68
Organon LLC
$60
AstraZeneca Pharmaceuticals LP
$60
Teva Pharmaceuticals USA, Inc.
$58
Bayer HealthCare Pharmaceuticals Inc.
$57
Pharmacyclics LLC, an AbbVie Company
$54
GENZYME CORPORATION
$50
Takeda Pharmaceuticals U.S.A., Inc.
$46
Shionogi Inc
$45
ARRAY BIOPHARMA INC
$36
Horizon Therapeutics plc
$36
SANOFI-AVENTIS U.S. LLC
$35
JAZZ PHARMACEUTICALS INC.
$31
ABBVIE INC.
$29
Octapharma USA, Inc.
$28
TAIHO ONCOLOGY, INC.
$27
Celgene Corporation
$26
Melinta Therapeutics, LLC
$25
Global Blood Therapeutics, Inc.
$24
PUMA BIOTECHNOLOGY, INC.
$23
Incyte Corporation
$23
Grifols USA, LLC
$21
Sobi, Inc
$20
Ipsen Biopharmaceuticals, Inc
$20
Merck Sharp & Dohme Corporation
$19
Astellas Pharma US Inc
$18
Pharmacyclics LLC, An AbbVie Company
$17
Karyopharm Therapeutics Inc.
$17
Cumberland Pharmaceuticals, Inc.
$16
Gilead Sciences, Inc.
$15
Biogen, Inc.
$15
Epizyme, Inc.,
$14
Taiho Oncology, Inc.
$14
Top 3 companies account for 36.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ADUHELM · AVSOLA · BENDEKA · BENLYSTA · BRAFTOVI · DARZALEX · DOPTELET · ELITEK · ENHERTU · ERLEADA · EVENITY · Enhertu · FASENRA · FERAHEME · Fetroja · GAMMAGARD · Gamunex-C · HYQVIA · IMBRUVICA · INJECTAFER · INQOVI · JAKAFI · KANJINTI · KISQALI · Kimyrsa · LIBTAYO · LONSURF · NERLYNX · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OXBRYTA · Pomalyst · RENFLEXIS · SANCUSO · SARCLISA · SCEMBLIX · SKYRIZI · SOLIQUA · SOMATULINE DEPOT · STELARA · Stivarga · TASIGNA · TAZVERIK · TEPEZZA · TUKYSA · Trodelvy · Truxima · UPLIZNA · VERZENIO · VYEPTI · XPOVIO · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Family medicine physicians within 10 mi
3,235
Per 100K population
198.7
County median income
$104,553
Nearest hospital
NEW YORK STATE PSYCHIATRIC INSTITUTE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Siddiqui is a mixed practice specialist, with above-average Medicare volume (top 0% in NY), with low-engagement industry engagement in the top 20% of NY peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Siddiqui experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Siddiqui performed 94,920 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Siddiqui receive payments from pharmaceutical companies?
Yes. Dr. Siddiqui received a total of $2,570 from 42 companies across 124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Siddiqui's costs compare to other family medicine physicians in New York?
Dr. Siddiqui's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Siddiqui) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in New York
Browse family medicine physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NY
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NY
Which NY family medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Lundbeck LLC Payments to Doctors
See all physicians who received payments from Lundbeck LLC.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology